NEW YORK, July 16 (GenomeWeb News) - GenoMed has amended its deal with venture capital group Pierpoint Investissements, allowing it to obtain up to $21 million in funding more quickly, the company said yesterday.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.